By Karlee Weinmann ( December 8, 2014, 12:22 PM EST) -- Merck & Co. Inc. said Monday it would absorb Cubist Pharmaceuticals in a deal worth $9.5 billion including debt, its second big-ticket acquisition this year and its first foray into treatments for drug-resistant superbugs....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.